Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe
Titel:
Cost-effectiveness of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma: a comparative analysis in China, the United States and Europe
Auteur:
Sun, Yuyang Xu, Kai Yao, Hongting Wei, Jingxuan Ding, Baolong Qian, Xiaodan Su, Dan Gong, Jinhong Shang, Jingjing Zhang, Lingli Li, Xin